Clinical trials recruiting for Early-Onset Alzheimer Disease
3
Recruiting trials
2
US states with sites
5
Countries
33%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1Phase 3 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ALN-APP | 1 |
| Donanemab | 1 |
| RG6289 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Indiana | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutation Carriers for the Treatment of Autosomal-Dominant Alzheimer's Disease
- A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
- FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Related conditions
Trials recruiting for Early-Onset Alzheimer Disease often also study these conditions. Each links to its own recruiting-trial list.
Alzheimer's disease 617Sickle cell disease 172Rare Diseases 7Pancreatic cancer 870Myasthenia Gravis 10Lung cancer 2180Huntington Disease 6Gaucher Disease 3Duchenne Muscular Dystrophy 3Cystic Fibrosis 11
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Early-Onset Alzheimer Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.